These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16514404)

  • 1. [Infliximab therapy in Crohn's disease complicated by Listeria monocytogenes meningoencephalitis].
    Ramanampamonjy RM; Laharie D; Bonnefoy B; Vergniol J; Amouretti M
    Gastroenterol Clin Biol; 2006 Jan; 30(1):157-8. PubMed ID: 16514404
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sepsis caused by Listeria monocytogenes related with the use of infliximab].
    de la Fuente Penco B; Marcó Piella A; Riera Mestre A; Boadas Mir J
    Med Clin (Barc); 2005 Mar; 124(10):398. PubMed ID: 15766516
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease.
    Izbéki F; Nagy F; Szepes Z; Kiss I; Lonovics J; Molnár T
    Inflamm Bowel Dis; 2008 Mar; 14(3):429-31. PubMed ID: 17973302
    [No Abstract]   [Full Text] [Related]  

  • 4. Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection.
    Campbell S; Ghosh S
    Eur J Gastroenterol Hepatol; 2001 Feb; 13(2):191-2. PubMed ID: 11246620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Meningitis due to Listeria monocytogenes as a complication of infliximab therapy].
    Joosten AA; van Olffen GH; Hageman G
    Ned Tijdschr Geneeskd; 2003 Jul; 147(30):1470-2. PubMed ID: 12908351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab in the management of the extra-intestinal manifestations of Crohn's disease.
    Lawrance IC
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1332-3. PubMed ID: 15482549
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic amyloidosis with Crohn's disease treated with infliximab.
    Park YK; Han DS; Eun CS
    Inflamm Bowel Dis; 2008 Mar; 14(3):431-2. PubMed ID: 17932971
    [No Abstract]   [Full Text] [Related]  

  • 8. [Indications and results of infliximab in Crohn's disease].
    Karoui S; Boubaker J; Filali A
    Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab treatment of an esophagobronchial fistula in a patient with extensive Crohn's disease of the esophagus.
    Ho IK; Guarino DP; Pertsovskiy Y; Cerulli MA
    J Clin Gastroenterol; 2002 Apr; 34(4):488-9. PubMed ID: 11907371
    [No Abstract]   [Full Text] [Related]  

  • 10. Infliximab for the treatment of metastatic hepatic and pulmonary Crohn's disease.
    Gill KR; Mahadevan U
    Inflamm Bowel Dis; 2005 Feb; 11(2):210-2. PubMed ID: 15677920
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term oral tacrolimus in refractory to infliximab fistulizing Crohn's disease: comments from Spanish experience.
    González Lama Y; Abreu LE; Vera MI; de la Revilla J; Fernandez-Puga N; Escartin P
    Gastroenterology; 2004 Mar; 126(3):942-3; author reply 943. PubMed ID: 14988864
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe polyneuropathy complicating active Crohn's disease: rapid response to Infliximab.
    Rodinò S; Saccà N; D'Amico T; Fragomeni A; Giglio A
    Gut; 2003 Jul; 52(7):1070. PubMed ID: 12801971
    [No Abstract]   [Full Text] [Related]  

  • 13. Infliximab in Crohn's disease-associated toxic megacolon.
    van Geenen EJ; Sachar DB
    J Clin Gastroenterol; 2012 Apr; 46(4):321-3. PubMed ID: 21857531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closure of jejuno-colic fistula in Crohn's disease with infliximab.
    Sood A; Midha V; Sood N
    Indian J Gastroenterol; 2001; 20(4):164-5. PubMed ID: 11497186
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of hereditary hemorrhagic telangiectasia associated with Crohn's disease successfully treated with infliximab.
    Papa A; Felice C; Marzo M; Guidi L
    Am J Gastroenterol; 2010 Aug; 105(8):1904. PubMed ID: 20686472
    [No Abstract]   [Full Text] [Related]  

  • 16. [Listeria meningitis in a patient with Crohn's disease--a seldom, but clinically relevant adverse event of therapy with infliximab].
    Dederichs F; Pinciu F; Gerhard H; Eveld K; Stallmach A
    Z Gastroenterol; 2006 Aug; 44(8):657-60. PubMed ID: 16902896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid response of severe refractory metastatic Crohn's disease to infliximab.
    Miller AM; Elliott PR; Fink R; Connell W
    J Gastroenterol Hepatol; 2001 Aug; 16(8):940-2. PubMed ID: 11555113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab for the treatment of hidradenitis suppurativa.
    Lebwohl B; Sapadin AN
    J Am Acad Dermatol; 2003 Nov; 49(5 Suppl):S275-6. PubMed ID: 14576652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Maintenance therapy with biologic agents for Crohn's disease: impact of scheduled maintenance therapy with infliximab].
    Endo K; Shiga H; Kakuta Y; Takahashi S; Kinouchi Y; Shimosegawa T
    Nihon Shokakibyo Gakkai Zasshi; 2011 Mar; 108(3):401-9. PubMed ID: 21389661
    [No Abstract]   [Full Text] [Related]  

  • 20. Infliximab as first-line therapy for severe Crohn's disease?
    Cohen RD
    Inflamm Bowel Dis; 2002 Jan; 8(1):58-9; discussion 63-5. PubMed ID: 11837940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.